Like rock posters, album art, and comix, blotter art played a crucial role in shaping the counterculture experience. The post...
Wheat – the most widely cultivated crop in the world – is under growing attack from harmful toxins. Across Europe, almost half of wheat crops are...
The article PharmaTher Receives FDA Orphan Drug Designation for Ketamine was originally published on Microdose. For more on Pharmather, check out PharmaTher...
'Tis the season to enhance your loved ones mind-altering experiences with just the right psychedelically inspired gift. The post A Holiday Gift Guide for...
Company also closed a C$3 million capital raise. The post Psyence Gets Approval For Psilocybin Drug For Palliative Care appeared first on Green Market...
The trial will be held at 7 NHS sites in the U.K. with the NIHR funding 66% of the cost The post Awakn set to research...
The reality of what psilocybin is and what it does within the human body is difficult to pinpoint. The post Psychedelics Could Change Human Evolution –...
Field Trip Health & Wellness Ltd. (TSXV: FTHW), a global leader in the delivery of psychedelic therapies, today announced that Ronan Levy, Chairman...
Core One Labs Inc. (CSE: COOL | OTCQB: CLABF | Frankfurt: LD6, WKN: A3CSSU) the Company is pleased to announce that its wholly-owned subsidiary, Vocan...
The article Mydecine Closes Sale of Mindleap for $3.6 million was originally published on Microdose. Starting this summer, we began reporting on the apparent...
The company filed provisional patents for the use of psilocybin to treat binge eating disorder and fibromyalgia. The post Tryp’s Clinical Psychedelics...
Psychedelics were once thought to provide fun trips and little else. Now, we know that psychedelics have the potential to provide a variety of benefits....
Much like the cannabis industry, there is no standard set for what a legal psychedelics programs looks like. The post State-Legal Psychedelics Therapy...
Source: Streetwise Reports 12/12/2022 Clinical-stage Algernon Pharmaceuticals' multiple pipelines include testing a psychedelic for the treatment...
The article Awakn’s Phase 3 Trial Launching With UK National Health Service was originally published on Microdose. Awakn Life Sciences has announced...
Awakn Life Sciences Corp. (NEO: AWKN | OTCQB: AWKNF | FSE: 954), a revenue-generating biotechnology company researching, developing, and commercializing...